Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation
Impurities compounds in any pharmaceutical product or drug substance are inevitable from a chemistry point of view. The quality and safety of a pharmaceutical product are also significantly affected by these impurities content; therefore, impurities need to be identified and characterized through th...
Saved in:
Main Authors: | Raymond R. Tjandrawinata, Antonius H. Cahyana, Ajeng O. Nugroho, Indra K. Adi, Joseph S. R. Talpaneni |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Advances in Pharmacological and Pharmaceutical Sciences |
Online Access: | http://dx.doi.org/10.1155/2024/5583526 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of HPLC with ELSD Detection for the Assessment of Azelaic Acid Impurities in Liposomal Formulation
by: Stanislaw Han, et al.
Published: (2013-01-01) -
Practical Approach for the Determination of Response Factors of Impurities in Drugs by HPLC
by: Dharmendra Kushwah, et al.
Published: (2011-01-01) -
Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson’s Disease: A Pilot Study
by: Haiyan Zhou, et al.
Published: (2021-01-01) -
Pramipexole Extended Release: A Novel Treatment Option in Parkinson's Disease
by: Wolfram Eisenreich, et al.
Published: (2010-01-01) -
Synthesis and Characterization of Process-Related Impurities of Antihypertensive Drug Olmesartan Medoxomil
by: G. Venkanna, et al.
Published: (2013-01-01)